At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MAA Mid-America Apartment Communities
Trading 10-15 15:12:22 EDT
115.77
+0.15
+0.13%
High116.52Low115.34Vol599.29K
Open116.50D1 Closing115.62Amplitude1.02%
Mkt Cap13.47BTradable Cap13.35BTotal Shares116.35M
T/O69.46MT/O Rate0.52%Tradable Shares115.34M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Mid-America Apartment is Maintained at Neutral by UBS
Dow Jones  ·  10-15 00:07
Mid-America Apartment is Maintained at Neutral by UBS
MAA price target lowered to $124 from $129 at UBS
TIPRANKS  ·  10-14 20:21
MAA price target lowered to $124 from $129 at UBS
Barclays Adjusts Price Target on Mid-America Apartment Communities to $136 From $146
MT Newswires Live  ·  10-14 17:44
Barclays Adjusts Price Target on Mid-America Apartment Communities to $136 From $146
RBC Capital Sticks to Their Hold Rating for MAA (MAA)
TIPRANKS  ·  10-14 09:48
RBC Capital Sticks to Their Hold Rating for MAA (MAA)
Jefferies & Co Adjusts Mid-America Apartment Communities Price Target to $128 From $152
MT Newswires Live  ·  10-12
Jefferies & Co Adjusts Mid-America Apartment Communities Price Target to $128 From $152
Mid-America Apartment Communities Inc : Jefferies Cuts Target Price to $128 from $152
THOMSON REUTERS  ·  10-12
Mid-America Apartment Communities Inc : Jefferies Cuts Target Price to $128 from $152
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia
GlobeNewswire  ·  10-09
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia
Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet
GlobeNewswire  ·  10-09
Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet
With Mortgage Rates Soaring Above 7.5%, the Smart Money Rents in America
Dow Jones  ·  10-09
With Mortgage Rates Soaring Above 7.5%, the Smart Money Rents in America
Mid America Apartment Communities (MAA) Stock Looks Undervalued After A 30% Five Year Slide
Simply Wall St.  ·  10-08
Mid America Apartment Communities (MAA) Stock Looks Undervalued After A 30% Five Year Slide
Mid-America Apartment Communities Inc. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  10-08
Mid-America Apartment Communities Inc. Stock Underperforms Wednesday When Compared to Competitors
Mid-America Apartment Communities Sets Third-Quarter 2026 Earnings Release, Call
Reuters  ·  10-08
Mid-America Apartment Communities Sets Third-Quarter 2026 Earnings Release, Call
BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
GlobeNewswire  ·  10-06
BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
Mid-America Apartment Communities Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains
Dow Jones  ·  10-06
Mid-America Apartment Communities Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains
Scotiabank Sticks to Their Sell Rating for MAA (MAA)
TIPRANKS  ·  10-05
Scotiabank Sticks to Their Sell Rating for MAA (MAA)
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
GlobeNewswire  ·  10-02
Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
Mid-America Apartment Communities Inc. Stock Underperforms Thursday When Compared to Competitors
Dow Jones  ·  10-02
Mid-America Apartment Communities Inc. Stock Underperforms Thursday When Compared to Competitors
Evercore ISI Trims Mid-America Apartment Price Target to $122 From $123, Maintains In Line Rating
MT Newswires Live  ·  10-01
Evercore ISI Trims Mid-America Apartment Price Target to $122 From $123, Maintains In Line Rating
Press Release: MaaT Pharma Publishes Its Half-Year 2026 Results and Provides a Business Update
Dow Jones  ·  09-30
Press Release: MaaT Pharma Publishes Its Half-Year 2026 Results and Provides a Business Update
Mid-America Apartment Communities Announces R$ 0.441230239 Dividend Per Unit for Q4 2026
Reuters  ·  09-25
Mid-America Apartment Communities Announces R$ 0.441230239 Dividend Per Unit for Q4 2026

Introduction

Company Name.
Mid-America Apartment Communities
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
MAA, an S&P 500 company, is a real estate investment trust (REIT) focused on delivering full-cycle and superior investment performance for shareholders through the ownership, management, acquisition, development and redevelopment of quality apartment communities primarily in the Southeast, Southwest and Mid-Atlantic regions of the United States. As of June 30, 2024, MAA had ownership interest in 103,614 apartment units, including communities currently in development, across 16 states and the District of Columbia.
Issue price:
--